Insider Profile
Wise, Adam Thomas
1
Companies Filed At
2
Open-Market Buys (2yr)
$193K
Buy Value (2yr, open-market)
Mar 31, 2026
Most Recent Trade
13
Credibility
Score
100%
Hit Rate
+16.9%
Avg 90d Return
+16.9%
Median 90d Return
2
Evaluated Trades
+16.9%
Best Trade
+16.9%
Worst Trade
Hit rate and returns are based on 2 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
THIN HISTORY
100%
Hit Rate · 90d
+5.4%
Median Alpha · 90d
2
Closed Buys Evaluated
50%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 2 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Mar 31, 2026 $MFC
Manulife Financial
Plan / DRIP Buy 54 78
Mar 31, 2026 $MFC
Manulife Financial
Plan / DRIP Buy 2,036 78
Mar 10, 2026 $MFC
Manulife Financial
Open Market Buy 3,500 $33.74 $118K 78
Mar 07, 2026 $MFC
Manulife Financial
Other Sell 21,640 $48.41 $1.0M 78
Dec 31, 2025 $MFC
Manulife Financial
Plan / DRIP Buy 1,001 78
Dec 31, 2025 $MFC
Manulife Financial
Plan / DRIP Buy 106 78
Dec 31, 2025 $MFC
Manulife Financial
Plan / DRIP Buy 60 78
Dec 03, 2025 $MFC
Manulife Financial
Open Market Buy 2,150 $34.95 $75K 78
Sep 30, 2025 $MFC
Manulife Financial
Plan / DRIP Buy 68 78
Sep 30, 2025 $MFC
Manulife Financial
Plan / DRIP Buy 137 78
Jun 16, 2025 $MFC
Manulife Financial
Other Sell 78
Jun 16, 2025 $MFC
Manulife Financial
Other Sell 78
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.